Abiopharma

New Form 8-K - Protalix BioTherapeutics, Inc. Filed: 2025-08-22 AccNo: 0001104659-25-081924 Size: 234 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits